Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY – Get Free Report)’s share price gapped up prior to trading on Monday. The stock had previously closed at $3.94, but opened at $4.0990. Hypermarcas shares last traded at $3.91, with a volume of 3,190 shares.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Hypermarcas has an average rating of “Buy”.

Read Our Latest Stock Analysis on Hypermarcas

Hypermarcas Trading Down 1.9%

The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 0.50. The business’s fifty day simple moving average is $4.61 and its two-hundred day simple moving average is $4.40. The stock has a market capitalization of $2.72 billion, a P/E ratio of 7.43 and a beta of 0.78.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its quarterly earnings data on Wednesday, November 11th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.01. The company had revenue of $473.13 million for the quarter, compared to the consensus estimate of $450.75 million. Hypermarcas had a net margin of 20.07% and a return on equity of 12.58%. As a group, analysts forecast that Hypermarcas will post 0.50 earnings per share for the current year.

About Hypermarcas

(Get Free Report)

Hypermarcas was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories. Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo QuĂ­mica and Mantecorp.

Read More

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.